KALBERMATTEN ADAM R purchased $49K of KRMD
KALBERMATTEN ADAM R (President-Chief Commercial Off) purchased 12,500 shares of KORU Medical Systems, Inc. (KRMD) at an average of $3.94 ($3.93–$3.96) across 2 trades on 2026-06-11.
How this was made
The 30-second read
Why it matters
The newest fact is the officer’s open-market purchase details (shares, price range, total value) disclosed via EDGAR.
Market read
Provides a fresh, primary-source insider buying datapoint that may slightly influence short-term sentiment toward KRMD.
What to watch
The filing notes no pre-arranged 10b5-1 plan; traders may still discount the signal if the buy size is small relative to typical insider activity or if broader company catalysts are absent.
Background
The article is an SEC Form 4 insider transaction disclosure for KORU Medical Systems, Inc. (KRMD).
Ticker impact
SEC Form 4 shows KRMD President-Chief Commercial Officer bought 12,500 shares open-market at ~$3.94 on 2026-06-11.
Likely limited near-term impact; any effect should be small and fade unless followed by additional disclosures or company-specific news.
Form 4 insider buys are typically incremental signals; the article provides no new operational/financial development beyond the transaction details.
Market effects
No sector-level read-through; this is a single-company insider transaction.
None indicated.
None indicated.
Counterpoint
Insider buys can be driven by diversification, liquidity needs, or routine compensation-related activity rather than a bullish view.
Key entities
- issuerKORU Medical Systems, Inc.
Company whose insider transaction is disclosed on Form 4.
- insiderKALBERMATTEN ADAM R
President-Chief Commercial Officer who purchased KRMD shares.